Search | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Displaying 1 result.

- Journal article
A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2).
Geven, Christopher Blet, Alice Kox, Matthijs Hartmann, Oliver Scigalla, Paul Zimmermann, Jens Marx, Gernot Laterre, Pierre-François[UCL] Mebazaa, Alexandre Pickkers, Peter (2019) BMJ open — Vol. 9, no.2, p. e024475 [1-11] (2019)